Search

everythinglearnresearchcommunity

for

Search:↓

Dermal exosomes with miR-218-5p boost hair growth by controlling β-catenin signaling.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

The document concludes that recognizing and properly diagnosing lipodystrophy syndromes is crucial for effective management and treatment.

HIV can cause unusual and severe skin problems that are hard to treat.

RANK is a key target in breast cancer treatment due to its role in tumor growth and bone metastasis.

Hair loss is common in lupus patients and can be permanent or reversible, depending on the type, with various treatments available.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

Patient had scalp allergy from minoxidil; test helped identify cause and suggest alternative treatments.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

Long-term fluticasone treatment does not harm the immune system in horses with heaves.

Systemic Lupus Erythematosus has varied symptoms and is hard to diagnose, affecting many body parts and requiring careful clinical judgment.

Psychotropic medications can cause skin reactions, including severe conditions like SJS and TEN, and it's important for psychiatrists to recognize and manage these side effects.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Trichoscopy is useful for diagnosing and monitoring systemic lupus erythematosus, with certain hair and scalp changes indicating more active disease.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

Skin aging is caused by stem cell damage and can potentially be delayed with treatments like antioxidants and stem cell therapy.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

Hydroxychloroquine showed some potential, but overall, the three drugs had limited success in treating lupus in dogs.

Mesenchymal stromal cells may help treat severe COVID-19, but more research is needed to confirm their effectiveness.

Lupus panniculitis of the scalp causes linear hair loss and needs ongoing treatment to prevent recurrence and lupus.

Juniperus plants contain compounds with potential for developing various medical treatments.

Chronic kidney disease can cause skin problems that affect patient quality of life, and treating these conditions can improve outcomes.

Using systemic drugs as creams for skin conditions shows promise, but more research is needed to confirm their effectiveness and safety.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

Some anticonvulsant drugs can cause skin reactions, ranging from mild to severe, and managing these reactions is important for patient care.

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.

Alopecia Areata is an autoimmune hair loss condition that needs more research for better treatments.

New treatments and early diagnosis methods for permanent hair loss due to scar tissue are important for managing its psychological effects.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.